2014). In our study, circulating IL-17 levels were significantly reduced in the intervention group, which indicated that the treatment might have had an effect on lesion cell activities and inflammation in atherosclerotic lesions (de Boer et al. 2010; van Bruggen and Ouyang 2014). Here, IL17A is linked to Atherosclerotic lesion.